Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Metabotropic glutamate receptor 2 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | Metabotropic glutamate receptor 2 | 872 aa | 822 aa | 21.2 % |
Onchocerca volvulus | Metabotropic glutamate receptor 2 | 872 aa | 774 aa | 20.4 % | |
Onchocerca volvulus | Golgi-associated plant pathogenesis-related protein 1 homolog | Metabotropic glutamate receptor 2 | 872 aa | 884 aa | 35.3 % |
Schistosoma mansoni | metabotropic glutamate receptor | Metabotropic glutamate receptor 2 | 872 aa | 892 aa | 26.9 % |
Onchocerca volvulus | Cell death abnormality protein 8 homolog | Metabotropic glutamate receptor 2 | 872 aa | 883 aa | 43.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0268 | 0.919 | 0.9172 |
Echinococcus granulosus | metabotropic glutamate receptor 5 | 0.0075 | 0.1927 | 0.2572 |
Echinococcus multilocularis | tar DNA binding protein | 0.0067 | 0.1622 | 0.2074 |
Loa Loa (eye worm) | hypothetical protein | 0.0072 | 0.1814 | 0.1814 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0106 | 0.3072 | 0.2919 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0196 | 0.6471 | 1 |
Loa Loa (eye worm) | glutaminase | 0.029 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0033 | 0.0354 | 0.014 |
Loa Loa (eye worm) | hypothetical protein | 0.0268 | 0.919 | 0.919 |
Schistosoma mansoni | hypothetical protein | 0.0072 | 0.1814 | 0.1633 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0072 | 0.1814 | 0.1633 |
Loa Loa (eye worm) | TAR-binding protein | 0.0067 | 0.1622 | 0.1622 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0038 | 0.053 | 0.0321 |
Brugia malayi | photoreceptor-specific nuclear receptor | 0.0261 | 0.8915 | 0.8891 |
Schistosoma mansoni | metabotropic glutamate receptor | 0.0051 | 0.1022 | 0.0824 |
Entamoeba histolytica | hypothetical protein | 0.0038 | 0.053 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0033 | 0.0354 | 0.014 |
Schistosoma mansoni | tar DNA-binding protein | 0.0067 | 0.1622 | 0.1437 |
Schistosoma mansoni | metabotropic glutamate receptor 2 3 (mglur group 2) | 0.0069 | 0.1711 | 0.1527 |
Schistosoma mansoni | hypothetical protein | 0.0038 | 0.053 | 0.0321 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0038 | 0.053 | 0.0289 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0038 | 0.053 | 0.0289 |
Brugia malayi | Metabotropic glutamate receptor precursor. | 0.0061 | 0.1395 | 0.1205 |
Schistosoma mansoni | hypothetical protein | 0.0033 | 0.0354 | 0.014 |
Loa Loa (eye worm) | glutaminase 2 | 0.029 | 1 | 1 |
Echinococcus multilocularis | metabotropic glutamate receptor 5 | 0.0075 | 0.1927 | 0.2572 |
Loa Loa (eye worm) | glutamate receptor | 0.0061 | 0.1395 | 0.1395 |
Schistosoma mansoni | tar DNA-binding protein | 0.0067 | 0.1622 | 0.1437 |
Entamoeba histolytica | hypothetical protein | 0.0038 | 0.053 | 0.5 |
Brugia malayi | RNA binding protein | 0.0067 | 0.1622 | 0.1437 |
Schistosoma mansoni | tar DNA-binding protein | 0.0067 | 0.1622 | 0.1437 |
Mycobacterium ulcerans | glutaminase | 0.029 | 1 | 0.5 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0033 | 0.0354 | 0.0354 |
Entamoeba histolytica | hypothetical protein | 0.0038 | 0.053 | 0.5 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0067 | 0.1622 | 0.1622 |
Echinococcus granulosus | tar DNA binding protein | 0.0067 | 0.1622 | 0.2074 |
Schistosoma mansoni | glutaminase | 0.029 | 1 | 1 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0033 | 0.0354 | 0.014 |
Brugia malayi | TAR-binding protein | 0.0067 | 0.1622 | 0.1437 |
Brugia malayi | metabotropic glutamate receptor subtype 5a (mGluR5a), putative | 0.0055 | 0.1179 | 0.0984 |
Loa Loa (eye worm) | RNA binding protein | 0.0067 | 0.1622 | 0.1622 |
Loa Loa (eye worm) | hypothetical protein | 0.0261 | 0.8915 | 0.8915 |
Schistosoma mansoni | hypothetical protein | 0.0033 | 0.0354 | 0.014 |
Brugia malayi | hypothetical protein | 0.0038 | 0.053 | 0.0321 |
Echinococcus multilocularis | metabotropic glutamate receptor 2 | 0.0051 | 0.1022 | 0.1093 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0196 | 0.6471 | 1 |
Trichomonas vaginalis | glutaminase, putative | 0.029 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0075 | 0.1927 | 0.1927 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0033 | 0.0354 | 0.014 |
Echinococcus granulosus | metabotropic glutamate receptor 2 | 0.0051 | 0.1022 | 0.1093 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0067 | 0.1622 | 0.1437 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0106 | 0.3072 | 0.3072 |
Schistosoma mansoni | tar DNA-binding protein | 0.0067 | 0.1622 | 0.1437 |
Schistosoma mansoni | tar DNA-binding protein | 0.0067 | 0.1622 | 0.1437 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.0354 | 0.0354 |
Entamoeba histolytica | hypothetical protein | 0.0038 | 0.053 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (binding) | = 0.31 uM | Positive allosteric modulation of rat mGluR2 expressed in HEK-293 cells assessed as thallium flux through GIRK channels | ChEMBL. | 21155570 |
Emax (binding) | = 64 % | Positive allosteric modulation of rat mGluR2 expressed in HEK-293 cells assessed as thallium flux through GIRK channels relative to glutamate | ChEMBL. | 21155570 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.